Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Ephrin Receptor B2 Expression May Be a Prognostic Marker for Patients With Cancer: A Meta-analysis

HYUN MIN KOH, CHANG LIM HYUN, BO GUN JANG and HYUN JU LEE
Anticancer Research August 2020, 40 (8) 4309-4317; DOI: https://doi.org/10.21873/anticanres.14433
HYUN MIN KOH
1Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHANG LIM HYUN
2Department of Pathology, Jeju National University School of Medicine, Jeju, Republic of Korea
3Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BO GUN JANG
2Department of Pathology, Jeju National University School of Medicine, Jeju, Republic of Korea
3Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HYUN JU LEE
4Department of Pathology, Soonchunhyang University College of Medicine, Cheonan, Republic of Korea
5Department of Pathology, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: drlhjmd{at}daum.net
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 8 4309-4317
DOI 
https://doi.org/10.21873/anticanres.14433
PMID 
32727758

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 4, 2020
  • Revision received June 30, 2020
  • Accepted July 1, 2020
  • Published online July 29, 2020.

Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. HYUN MIN KOH1,
  2. CHANG LIM HYUN2,3,
  3. BO GUN JANG2,3 and
  4. HYUN JU LEE4,5⇑
  1. 1Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea
  2. 2Department of Pathology, Jeju National University School of Medicine, Jeju, Republic of Korea
  3. 3Department of Pathology, Jeju National University Hospital, Jeju, Republic of Korea
  4. 4Department of Pathology, Soonchunhyang University College of Medicine, Cheonan, Republic of Korea
  5. 5Department of Pathology, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea
  1. Correspondence to: Hyun Ju Lee, MD, Ph.D., Department of Pathology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, 31 Soonchunhyang 6 gil, Dongnam-gu, Cheonan-si, Chungcheongnam-do, 330-721, Republic of Korea. Tel: +82 415701499, Fax: +82 415703580, e-mail: drlhjmd{at}daum.net
View Full Text

Statistics from Altmetric.com

Cited By...

  • 4 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 8
August 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ephrin Receptor B2 Expression May Be a Prognostic Marker for Patients With Cancer: A Meta-analysis
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Ephrin Receptor B2 Expression May Be a Prognostic Marker for Patients With Cancer: A Meta-analysis
HYUN MIN KOH, CHANG LIM HYUN, BO GUN JANG, HYUN JU LEE
Anticancer Research Aug 2020, 40 (8) 4309-4317; DOI: 10.21873/anticanres.14433

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Ephrin Receptor B2 Expression May Be a Prognostic Marker for Patients With Cancer: A Meta-analysis
HYUN MIN KOH, CHANG LIM HYUN, BO GUN JANG, HYUN JU LEE
Anticancer Research Aug 2020, 40 (8) 4309-4317; DOI: 10.21873/anticanres.14433
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Potential of Inflammatory and Nutritional Markers and Clinicopathological Factors for Prognostic Prediction in Osteosarcoma
  • Diameter of IPDA Is Associated With Maintenance of Hepatic Arterial Blood Flow in DP-CAR
  • Postoperative Changes in Nutritional Status and their Impact on Post-recurrence Prognosis After Pancreatoduodenectomy in Patients With Biliary Tract Carcinoma: An Age-stratified Analysis
Show more Clinical Studies

Keywords

  • cancer
  • ephrin receptor B2
  • meta-analysis
  • prognosis
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire